Results from a three-year trial suggest an experimental gene therapy for Huntington's disease can slow the progression of the ...

In the Mitchell area, therapy might soon sound more like a jam session than a clinical appointment. That's because music therapy — a board-certified, evidence-based healthcare practice — is coming to ...

Topline data were announced from a pivotal phase 1/2 study evaluating AMT-130 in patients with Huntington disease.

An experimental gene therapy was found to slow the progression of Huntington's disease, marking a major step toward a ...

AMT-130 has been granted Breakthrough Therapy designation and Regenerative Medicine Advanced Therapy (RMAT) designation from the FDA.

Huntington's disease devastates families around the world and is still without a cure. But UK researchers have hope for future treatment following clinical trials involving gene therapy.

Breakthrough Therapy designation granted based on FDA’s review of available clinical evidence of safety and efficacy from all 12 patients treated ...

Bayer first company to advance cell therapy as well as gene therapy against Parkinson’s disease: Berlin Tuesday, September 23, 2025, 10:00 Hrs [IST] Bayer announced progress for ...

Groundbreaking study demonstrates that targeted oligodendrocyte gene therapy leads to decreased N-acetylaspartate (NAA) levels and increased ...

AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced that the first European participants have been randomized in ...

David Baker’s Nobel Prize-winning lab has designed protein on/off switches as a tool for tunable cancer immunotherapies and biosensors.